当前位置: »论坛 › 科研专区 › 文献互助› Safety, Biodistribution, and Dosimetry of FAP and In ...

[其他期刊] Safety, Biodistribution, and Dosimetry of FAP and Integrin αvβ3Dual-Targeting Radioligand177Lu-DOTA-FAPI-RGD: Preclinical Validation and First-in-Human Study in Patients with Advanced Adenocarcinomas

求助已关闭

totoru 发表于 2026-8-31 14:36:24 | 显示全部楼层 |阅读模式

悬赏30积分

本帖最后由 totoru 于 2026-8-31 14:38 编辑

期刊：Journal of Nuclear Medicine

文献作者：Jialin Xiang; Xuejun Wen; Rongxi Wang; Jiarou Wang; Xingtong Peng; Yanwei Wang; Naixin Liang; Dongyan Cao; Xiaoyuan Chen; Zhaohui Zhu; Jingjing Zhang

出版日期：--

DOI号：10.2967/jnumed.126.272007

下载链接：https://syndication.highwire.org ... 7/jnumed.126.272007

文献链接：https://doi.org/10.2967/jnumed.126.272007

当前文献来源于 Society of Nuclear Medicine。

备注信息：请同时下载附件（Supplemental Data）

使用道具捐赠获取积分应助有误反馈

全部回复0 显示全部楼层

发表回复

totoru Lv.4

VIP会员

发布
回复
积分
1260

[其他期刊] Safety, Biodistribution, and Dosimetry of FAP and Integrin αvβ3Dual-Targeting Radioligand177Lu-DOTA-FAPI-RGD: Preclinical Validation and First-in-Human Study in Patients with Advanced Adenocarcinomas

发表回复

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[其他期刊] Safety, Biodistribution, and Dosimetry of FAP and Integrin αvβ3Dual-Targeting Radioligand177Lu-DOTA-FAPI-RGD: Preclinical Validation and First-in-Human Study in Patients with Advanced Adenocarcinomas 一键复制

发表回复

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[其他期刊] Safety, Biodistribution, and Dosimetry of FAP and Integrin αvβ3Dual-Targeting Radioligand177Lu-DOTA-FAPI-RGD: Preclinical Validation and First-in-Human Study in Patients with Advanced Adenocarcinomas